Baillie Gifford & Co. Sells 11,775 Shares of Trupanion, Inc. (NASDAQ:TRUP)

Baillie Gifford & Co. decreased its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 2.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 554,025 shares of the financial services provider's stock after selling 11,775 shares during the quarter. Baillie Gifford & Co. owned approximately 1.31% of Trupanion worth $23,258,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of TRUP. Vanguard Group Inc. increased its position in Trupanion by 0.9% during the first quarter. Vanguard Group Inc. now owns 3,673,791 shares of the financial services provider's stock worth $101,433,000 after buying an additional 32,485 shares during the last quarter. 8 Knots Management LLC increased its holdings in shares of Trupanion by 87.0% during the 1st quarter. 8 Knots Management LLC now owns 1,297,485 shares of the financial services provider's stock valued at $35,824,000 after acquiring an additional 603,775 shares during the last quarter. Marshall Wace LLP increased its holdings in shares of Trupanion by 11.9% during the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider's stock valued at $32,181,000 after acquiring an additional 116,496 shares during the last quarter. Renaissance Technologies LLC bought a new position in shares of Trupanion in the 2nd quarter valued at approximately $4,739,000. Finally, Dimensional Fund Advisors LP lifted its holdings in Trupanion by 24.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 137,833 shares of the financial services provider's stock worth $4,052,000 after purchasing an additional 26,941 shares during the last quarter.

Trupanion Stock Performance

Trupanion stock traded down $1.23 during trading hours on Wednesday, hitting $52.52. The stock had a trading volume of 611,869 shares, compared to its average volume of 685,156. Trupanion, Inc. has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The company has a market cap of $2.22 billion, a PE ratio of -167.06 and a beta of 1.69. The company has a 50-day moving average of $47.73 and a two-hundred day moving average of $37.82. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The firm had revenue of $327.50 million during the quarter, compared to analysts' expectations of $321.79 million. During the same period last year, the business earned ($0.10) earnings per share. Trupanion's quarterly revenue was up 14.6% compared to the same quarter last year. On average, equities research analysts anticipate that Trupanion, Inc. will post -0.23 EPS for the current fiscal year.

Insider Activity

In related news, CFO Fawwad Qureshi sold 640 shares of the stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $43.12, for a total value of $27,596.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Trupanion news, CFO Fawwad Qureshi sold 640 shares of Trupanion stock in a transaction on Friday, August 16th. The stock was sold at an average price of $43.12, for a total transaction of $27,596.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Murray B. Low sold 2,000 shares of the business's stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total transaction of $105,340.00. Following the completion of the sale, the director now owns 131,513 shares in the company, valued at $6,926,789.71. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 10,764 shares of company stock worth $510,578. Corporate insiders own 5.50% of the company's stock.

Wall Street Analysts Forecast Growth

TRUP has been the topic of several analyst reports. Northland Securities increased their price target on Trupanion from $45.00 to $50.00 and gave the company a "market perform" rating in a report on Thursday, October 31st. Piper Sandler boosted their target price on shares of Trupanion from $45.00 to $57.00 and gave the stock a "neutral" rating in a research report on Thursday, October 31st. William Blair assumed coverage on Trupanion in a research report on Friday, July 19th. They issued an "outperform" rating on the stock. Stifel Nicolaus boosted their price objective on Trupanion from $30.00 to $40.00 and gave the stock a "hold" rating in a research report on Monday, September 23rd. Finally, Bank of America increased their target price on Trupanion from $47.00 to $56.00 and gave the company a "buy" rating in a research note on Friday, September 20th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Trupanion currently has a consensus rating of "Moderate Buy" and a consensus price target of $44.67.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.